OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cellular and Humoral Immune Responses in Covid-19 and Immunotherapeutic Approaches
Amal Hasan, Ebaa Al‐Ozairi, Zahraa Albaqsumi, et al.
ImmunoTargets and Therapy (2021) Vol. Volume 10, pp. 63-85
Open Access | Times Cited: 49
Amal Hasan, Ebaa Al‐Ozairi, Zahraa Albaqsumi, et al.
ImmunoTargets and Therapy (2021) Vol. Volume 10, pp. 63-85
Open Access | Times Cited: 49
Showing 26-50 of 49 citing articles:
Characteristics of Natural Killer (NK) Cell and T Lymphocyte in COVID-19 patients in Surabaya, Indonesia
Munawaroh Fitriah, Betty Agustina Tambunan, Hartono Kahar, et al.
Research Journal of Pharmacy and Technology (2022), pp. 2198-2203
Closed Access | Times Cited: 4
Munawaroh Fitriah, Betty Agustina Tambunan, Hartono Kahar, et al.
Research Journal of Pharmacy and Technology (2022), pp. 2198-2203
Closed Access | Times Cited: 4
Performance of Whole Blood Stimulation Assays for the Quantification of SARS-CoV-2 Specific T-Cell Response: A Cross-Sectional Study
Federica Bergami, Francesca Arena, Eleonora Francesca Pattonieri, et al.
Diagnostics (2022) Vol. 12, Iss. 6, pp. 1509-1509
Open Access | Times Cited: 4
Federica Bergami, Francesca Arena, Eleonora Francesca Pattonieri, et al.
Diagnostics (2022) Vol. 12, Iss. 6, pp. 1509-1509
Open Access | Times Cited: 4
In Vitro Exposure of Primary Human T Cells and Monocytes to Polyclonal Stimuli Reveals a Basal Susceptibility to Display an Impaired Cellular Immune Response and Develop Severe COVID-19
Rebeca Viurcos-Sanabria, Aarón N. Manjarrez‐Reyna, Helena Solleiro-Villavicencio, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 3
Rebeca Viurcos-Sanabria, Aarón N. Manjarrez‐Reyna, Helena Solleiro-Villavicencio, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 3
RNA Viruses, Pregnancy and Vaccination: Emerging Lessons from COVID-19 and Ebola Virus Disease
C. R. Dhanya, Aswathy Shailaja, Aarcha Shanmugha Mary, et al.
Pathogens (2022) Vol. 11, Iss. 7, pp. 800-800
Open Access | Times Cited: 3
C. R. Dhanya, Aswathy Shailaja, Aarcha Shanmugha Mary, et al.
Pathogens (2022) Vol. 11, Iss. 7, pp. 800-800
Open Access | Times Cited: 3
Clinical and immunological features associated to the development of a sustained immune humoral response in COVID-19 patients: Results from a cohort study
Jiram Torres‐Ruiz, Julieta Lomelín‐Gascón, Ana Sofía Vargas-Castro, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 3
Jiram Torres‐Ruiz, Julieta Lomelín‐Gascón, Ana Sofía Vargas-Castro, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 3
Analysis of peripheral lymphocyte subsets and T-cell exhaustion in SARS-CoV-2 Infection
Şadan Soyyiğit, Dilek ÖKSÜZER ÇİMŞİR, Ali Öncül, et al.
Tuberkuloz ve Toraks (2024) Vol. 72, Iss. 2, pp. 152-166
Open Access
Şadan Soyyiğit, Dilek ÖKSÜZER ÇİMŞİR, Ali Öncül, et al.
Tuberkuloz ve Toraks (2024) Vol. 72, Iss. 2, pp. 152-166
Open Access
In-silico evaluation of the T-cell based immune response against SARS-CoV-2 omicron variants
Shivangi Sharma, Diya Roy, Sarah Cherian
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Shivangi Sharma, Diya Roy, Sarah Cherian
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Immune status in women after COVID-19 living in the subarctic region
L. S. Shchegoleva, E. Yu. Shashkova, М.S. Kabbani, et al.
Acta Biomedica Scientifica (East Siberian Biomedical Journal) (2024) Vol. 9, Iss. 5, pp. 96-106
Open Access
L. S. Shchegoleva, E. Yu. Shashkova, М.S. Kabbani, et al.
Acta Biomedica Scientifica (East Siberian Biomedical Journal) (2024) Vol. 9, Iss. 5, pp. 96-106
Open Access
Nanoadjuvants Produced by Advanced Nanochelating Technology in the Inactivated-Severe Acute Respiratory Syndrome Coronavirus-2 Vaccine Formulation: Preliminary Results on Cytokines and IgG Responses
Somayeh Kalanaky, Saideh Fakharzadeh, Pegah Karimi, et al.
Viral Immunology (2023) Vol. 36, Iss. 6, pp. 409-423
Closed Access | Times Cited: 1
Somayeh Kalanaky, Saideh Fakharzadeh, Pegah Karimi, et al.
Viral Immunology (2023) Vol. 36, Iss. 6, pp. 409-423
Closed Access | Times Cited: 1
Rationale for combined therapies in severe-to-critical COVID-19 patients
Aitor Gonzaga, Etelvina Andreu, Luis Blasco, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 1
Aitor Gonzaga, Etelvina Andreu, Luis Blasco, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 1
Examining Lifestyle Components in Hospitalized COVID-19 Patients, Iran 2021
Ali Soroush, Armin Naghipour, Behzad Heidarpour, et al.
Journal of Lifestyle Medicine (2022) Vol. 12, Iss. 1, pp. 56-61
Open Access | Times Cited: 2
Ali Soroush, Armin Naghipour, Behzad Heidarpour, et al.
Journal of Lifestyle Medicine (2022) Vol. 12, Iss. 1, pp. 56-61
Open Access | Times Cited: 2
Simulation of COVID-19 symptoms in a genetically engineered mouse model: implications for the long haulers
Mahavir Singh, Sathnur Pushpakumar, Nia Bard, et al.
Molecular and Cellular Biochemistry (2022) Vol. 478, Iss. 1, pp. 103-119
Open Access | Times Cited: 2
Mahavir Singh, Sathnur Pushpakumar, Nia Bard, et al.
Molecular and Cellular Biochemistry (2022) Vol. 478, Iss. 1, pp. 103-119
Open Access | Times Cited: 2
An Immune Response to Heterologous ChAdOx1/BNT162b2 Vaccination against COVID-19: Evaluation of the anti-RBD Specific IgG Antibodies Titers and Interferon Gamma Release Assay (IGRA) Test Results
Marzena Zalewska, Wiktoria Fus, Adam Konka, et al.
Vaccines (2022) Vol. 10, Iss. 9, pp. 1546-1546
Open Access | Times Cited: 2
Marzena Zalewska, Wiktoria Fus, Adam Konka, et al.
Vaccines (2022) Vol. 10, Iss. 9, pp. 1546-1546
Open Access | Times Cited: 2
Fatal COVID-19 is Associated with Reduced HLA-DR, CD123 or CD11c Expression on Circulating Dendritic Cells
Amal Hasan, Ebaa Al‐Ozairi, Nosiba YM Hassan, et al.
Journal of Inflammation Research (2022) Vol. Volume 15, pp. 5665-5675
Open Access | Times Cited: 2
Amal Hasan, Ebaa Al‐Ozairi, Nosiba YM Hassan, et al.
Journal of Inflammation Research (2022) Vol. Volume 15, pp. 5665-5675
Open Access | Times Cited: 2
Low Admission Immunoglobulin G Levels Predict Poor Outcome in Patients with Mild-to-Critical COVID-19: A Prospective, Single-Center Study
Charikleia S. Vrettou, Alice G. Vassiliou, Ιoannis Kakkas, et al.
Journal of Epidemiology and Global Health (2021) Vol. 11, Iss. 4, pp. 338-343
Open Access | Times Cited: 2
Charikleia S. Vrettou, Alice G. Vassiliou, Ιoannis Kakkas, et al.
Journal of Epidemiology and Global Health (2021) Vol. 11, Iss. 4, pp. 338-343
Open Access | Times Cited: 2
High individual heterogeneity of neutralizing activities against the original strain and 9 different variants of SARS-CoV-2
Rita Jaafar, Céline Boschi, Sarah Aherfi, et al.
Research Square (Research Square) (2021)
Closed Access | Times Cited: 2
Rita Jaafar, Céline Boschi, Sarah Aherfi, et al.
Research Square (Research Square) (2021)
Closed Access | Times Cited: 2
Stem Cells: A Promising Therapeutic Target for COVID-19
Leyla Tahrani Hardin, Nan Xiao
Stem Cell Discovery (2022) Vol. 12, Iss. 01, pp. 1-27
Open Access | Times Cited: 1
Leyla Tahrani Hardin, Nan Xiao
Stem Cell Discovery (2022) Vol. 12, Iss. 01, pp. 1-27
Open Access | Times Cited: 1
The New Variants of Corona-Virus Mutations: An Understanding to Their Infectivity, Immunological Tolerance and Vaccine Efficacy
Pankaj Garg
Nano LIFE (2021) Vol. 11, Iss. 03, pp. 2130010-2130010
Closed Access | Times Cited: 1
Pankaj Garg
Nano LIFE (2021) Vol. 11, Iss. 03, pp. 2130010-2130010
Closed Access | Times Cited: 1
Yoghurt (LAB) as preventive method against COVID-19
Karthik Bose, bose Karthik
Journal of Medical Clinical Case Reports (2023)
Open Access
Karthik Bose, bose Karthik
Journal of Medical Clinical Case Reports (2023)
Open Access
Retrospective Analysis of Demographic and Clinical Data in SARS-CoV-2 IgG Reactive Individuals Applied to Cerrahpaşa Medical Faculty Hospital: 1 Year Evaluation
Rüveyda Akçin, Tevhide Ziver, Okan Aydoğan, et al.
Flora the Journal of Infectious Diseases and Clinical Microbiology (2023) Vol. 28, Iss. 2, pp. 164-174
Open Access
Rüveyda Akçin, Tevhide Ziver, Okan Aydoğan, et al.
Flora the Journal of Infectious Diseases and Clinical Microbiology (2023) Vol. 28, Iss. 2, pp. 164-174
Open Access
Adaptive Immunity In Type Two Diabetes Mellitus (T2dm) Patients With Sars-Cov-2 (Covid-19) Infection
Pelin ALGAN ÖCAL
(2023)
Open Access
Pelin ALGAN ÖCAL
(2023)
Open Access
Nanochelating Technology: Simultaneous Enhancement of Cellular and Humoral Immune Responses by Nano-Adjuvant-Formulated Alum-Based Inactivated-Sars-Cov-2 Vaccines
Somayeh Kalanaky, Saideh Fakharzadeh, Pegah Karimi, et al.
SSRN Electronic Journal (2022)
Closed Access
Somayeh Kalanaky, Saideh Fakharzadeh, Pegah Karimi, et al.
SSRN Electronic Journal (2022)
Closed Access
Likelihood of COVID-19 reinfection in an urban community cohort in Massachusetts
Sharon M. Casey, Aaron Legler, Amresh Hanchate, et al.
Dialogues in Health (2022) Vol. 1, pp. 100057-100057
Open Access
Sharon M. Casey, Aaron Legler, Amresh Hanchate, et al.
Dialogues in Health (2022) Vol. 1, pp. 100057-100057
Open Access
High individual heterogeneity of neutralizing activities against the original 4 strain and 9 different variants of SARS-CoV-2
Rita Jaafar, Céline Boschi, Sarah Aherfi, et al.
Research Square (Research Square) (2021)
Closed Access
Rita Jaafar, Céline Boschi, Sarah Aherfi, et al.
Research Square (Research Square) (2021)
Closed Access
